Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Lung Cancer
Filter by Topic
Lung Adenocarcinoma
The Need for Immunotherapeutic Approaches for Lung Cancer
Lung Cancer
Read More ›
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Cancer Immunotherapy MPDL3280A (Anti–PD-L1) in Non–Small Cell Lung Cancer
Lung Cancer
Read More ›
Ramucirumab Conveys Survival Benefit in NSCLC
By
Maurice Pérol, MD
Lung Cancer
Read More ›
Navigating the Molecular Testing Landscape in Lung Cancer
By
Roy Herbst, MD, PhD
Lung Cancer
Read More ›
Treatment Paradigm for NSCLC May Be Shifting
Lung Cancer
Read More ›
Personalizing Therapy in the Management of Recurrent Non–Small Cell Lung Cancer: Case Study of a Patient With an EGFR Mutation
Lung Cancer
Read More ›
Resistance to Targeted Molecular Therapies in NSCLC
By
Melissa L. Johnson, MD
Lung Cancer
Read More ›
EGFR Mutations, Not KRAS Mutations, May Be Predictive for Sorafenib Response in Advanced NSCLC
By
Phoebe Starr
Lung Cancer
Read More ›
Crizotinib Extends Survival Versus Chemotherapy in Advanced NSCLC
By
Phoebe Starr
Lung Cancer
Read More ›
Crizotinib Miracle: A Nursing Perspective
By
Tara L. Rich, MSN, RN, CNP
Lung Cancer
Read More ›
Page 2 of 2
1
2